FDA Clears apoQlar’s Surgical Planning Software

The FDA has granted apoQlar 510(k) marketing clearance for its VSI HoloMedicine software device which helps surgeons plan complex procedures using 3D holograms created from flat imaging sources.

The software uses Microsoft’s HoloLens 2, a mixed-reality head-mounted display inside or outside the operating room. Computed tomography scans as well as magnetic resonance imaging and positive emission tomography scans can be used to create to the interactive 3D holograms.

The company says the system is now available in 30 countries with a U.S. rollout planned in the second quarter of 2023.